Patents Assigned to Aeropharm Technology, Inc.
  • Core formulation
    Patent number: 6780432
    Abstract: This invention relates to a combination drug product comprising pioglitazone hydrochloride and a biguamide, e.g. metformin. In particular, the product comprises a core of the biguamide, e.g. metformin, at least a portion thereof has a layer or coat thereon of pioglitazone.
    Type: Grant
    Filed: October 31, 2000
    Date of Patent: August 24, 2004
    Assignee: Aeropharm Technology, Inc.
    Inventors: Anthony J. Cutie, Akwete L. Adjei, Frederick A. Sexton
  • Modulated release particles for lung delivery
    Patent number: 6749845
    Abstract: A polymeric construct is disclosed. The construct comprises a polysaccharide polymer having a selected medicament associated therewith. The medicament thus present is provided in a slow release form.
    Type: Grant
    Filed: February 15, 2001
    Date of Patent: June 15, 2004
    Assignee: Aeropharm Technology, Inc.
    Inventors: Yaping Zhu, Simon G. Stefanos, Lukeysha Kline, Akwete L. Adjei
  • Core formulation
    Patent number: 6524621
    Abstract: This invention relates to a modulating formulation comprising pioglitazone hydrochloride and a biguamide, e.g. metformin. In particular, the product comprises a core of the biguamide, e.g. metformin, at least a portion thereof has a layer or coat thereon of pioglitazone.
    Type: Grant
    Filed: February 15, 2001
    Date of Patent: February 25, 2003
    Assignee: Aeropharm Technology Inc.
    Inventors: Akwete L. Adjei, Yaping Zhu, Anthony J. Cutie
  • Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer
    Patent number: 6468507
    Abstract: A non-aqueous medicinal aerosol formulation comprising rosiglitazone maleate, a fluid carrier, and an amino acid stabilizer. The aerosol formulation may also include drug combination formulations comprising rosiglitazone maleate and a second anti-diabetic medicament.
    Type: Grant
    Filed: October 31, 2000
    Date of Patent: October 22, 2002
    Assignee: Aeropharm Technology, Inc.
    Inventors: Anthony J. Cutie, Akwete L. Adjei, Frederick A. Sexton
  • Core formulation
    Patent number: 6461639
    Abstract: This invention relates to a controlled-release combination drug product comprising troglitazone, e.g. its hydrochloride, and a biguamide, e.g. metformin. In particular, the product comprises a core of metformin, at least a portion thereof has a layer or coat thereon of troglitazone.
    Type: Grant
    Filed: February 15, 2001
    Date of Patent: October 8, 2002
    Assignee: Aeropharm Technology, Inc.
    Inventors: Akwete L. Adjei, Yaping Zhu, Anthony J. Cutie
  • Method of treating a systemic disease
    Patent number: 6406681
    Abstract: A method of treating a systemic disease in a patient in need of such treatment is disclosed. The method comprising maintaining the inspiratory flow rate and volume of the patient to a certain value and then administering a medicament aerosol formulation to such patient.
    Type: Grant
    Filed: August 21, 2000
    Date of Patent: June 18, 2002
    Assignee: Aeropharm Technology, Inc.
    Inventors: Akwete L. Adjei, Anthony J. Cutie
  • Amino acid stabilized medical aerosol formulation
    Patent number: 6136294
    Abstract: This invention relates to a medicinal aerosol formulation and more particularly, to a medicinal aerosol formulation containing a particulate drug, a propellant and a stabilizing agent selected from an amino acid, an amino acid derivative and a mixture of the foregoing.
    Type: Grant
    Filed: September 22, 1998
    Date of Patent: October 24, 2000
    Assignee: Aeropharm Technology Inc.
    Inventors: Akwete Adjei, Anthony J. Cutie
  • Aerosol formulations containing a sugar as a dispersant
    Patent number: 6129905
    Abstract: Aerosol formulations for mucosal and/or topical administration containing one or more drugs and a sugar as a dispersant in a pharmaceutically acceptable propellant, are disclosed. Metered dose inhalers suitable for delivering such formulations are also disclosed.
    Type: Grant
    Filed: August 13, 1997
    Date of Patent: October 10, 2000
    Assignee: Aeropharm Technology, Inc.
    Inventor: Anthony J. Cutie